Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
September 16, 2025
Approximately 5 minutes
Australian Medical Device Registration: The Role of the Sponsor and TGA Inclusion
Australian Medical Device Registration: The Role of the Sponsor and TGA Inclusion
Medical device registration in Australia is overseen by the Therapeutic Goods Administration (TGA), which is part of the Australian Government's Department of Health. Non-Australian manufacturers must utilize an Australian Sponsor (or Authorized Representative) to facilitate the registration process and maintain compliance.
The Role of the Australian Sponsor
The Australian Sponsor is the primary local contact for the TGA and acts as the legal conduit between the manufacturer and the TGA. Their responsibilities include:
- Submitting the application for inclusion in the Australian Register of Therapeutic Goods (ARTG).
- Answering any questions from the TGA during the application and review process.
- Providing ongoing post-market surveillance and vigilance support.
- Ensuring the device maintains compliance with Australian regulations.
Registration Pathway and Essential Principles
To achieve ARTG inclusion, manufacturers must demonstrate that their medical device complies with the Essential Principles set out in the Therapeutic Goods Act 1989. These include six general principles that apply to all devices (e.g., safety, suitability for intended purpose) and nine further principles that apply on a case-by-case basis (e.g., chemical properties, clinical evidence).
The TGA offers an abridged regulatory review for products that have already demonstrated conformity in reference countries, including the European Union, the United States (FDA), Canada, Japan, and Singapore. Acceptable evidence of conformity to the Essential Principles includes:
- Certificates issued by EU Notified Bodies.
- Decisions by the U.S. Food and Drug Administration (FDA).
- Approvals and licenses issued by Health Canada.
- Certificates and reports issued under the Medical Device Single Audit Program (MDSAP).
Application and Audit Requirements
The TGA's regulatory review time and mandatory audit requirements depend on the device's risk classification (Class I, IIa, IIb, III, and Active Implantable Medical Devices - AIMD).
Review Times and Fees (AUD)
| Device Classification | Application Fee (AUD) | Estimated Review Time |
|---|---|---|
| Class I (sterile/measuring function) | $621 | Same day to 4 weeks |
| Class IIa | $1,187 | 4 weeks |
| Class IIb | $1,187 | 6 weeks |
| Class III | $1,530 | 6 months (incl. audit) |
Application Audit Assessment
Higher-risk products are subject to a mandatory audit where the TGA reviews the application and technical documentation:
- Level 1 Audit (Verification): Verifies the sponsor's application and evidence of conformity (Fee: A$4,700).
- Level 2 Audit (Mandatory for Class III and AIMD): Includes Level 1 activities plus an in-depth technical documentation review (Fee: A$17,288).
Annual Fees (AUD)
Annual fees are also mandatory to maintain the device's listing on the ARTG:
| Class of Medical Device | Annual Fee (AUD) |
|---|---|
| AIMD & Class III | $1,566 |
| Class IIb & IIa | $1,230 |
| Class I (sterile or measuring) | $828 |
| Class I (other) | $114 |
Quality System Requirements
The TGA requires manufacturers to meet ISO 13485:2016 standards, with additional specific requirements for products that are sold sterilized, which must adhere to relevant ISO standards (e.g., ISO 11135 for ethylene oxide sterilization).
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Medical Device Classification: TGA Risk-Based System
The TGA classifies medical devices based on risk, invasiveness, and intended use into Class I, IIa, IIb, III, and AIMD. This classification determines the required **Conformity Assessment** scrutiny, **Quality Management System (QMS)** requirements, and the complexity of achieving inclusion in the **Australian Register of Therapeutic Goods (ARTG)**.
Approximately 5 minutes
Australia Medical Device Labeling: TGA Compliance and Sponsor Requirements
Australian medical device labeling must adhere to the **TGA's Therapeutic Goods (Medical Devices) Regulations 2002**. The **Australian Sponsor's** name and address must appear on the outer packaging. Required information includes the device's intended use, manufacturer details, mandatory warnings, and full traceability data (batch/lot/serial number, and expiration date if applicable) to ensure safety and compliance with the Essential Principles.
Approximately 5 minutes
Australia Medical Device License Maintenance: Annual Charges and ARTG Variations
Maintaining medical device market access in Australia requires payment of mandatory **Annual Charges** to the TGA every August and submitting a **Variation to an ARTG inclusion entry** for any modifications. The Australian Sponsor is responsible for managing these obligations, which include updating **Manufacturer's Evidence** (e.g., renewed certificates, address changes) to prevent license revocation or suspension.
Approximately 5 minutes
Post-Market Surveillance: Sponsor's Role in TGA Vigilance
Post-Market Surveillance (PMS) in Australia is mandatory, with the **Australian Sponsor** being responsible for reporting all **Australian adverse incidents** and **overseas regulatory actions** to the TGA. For high-risk devices (AIMD, Class III, implantable Class IIb), the Sponsor must submit **three consecutive annual reports** detailing product complaints. The TGA uses these reports to initiate potential recalls, hazard alerts, or product modifications.